<p>0.9% saline-treated control group. The cell were recorded in 2 h after seeding on 6-well plate equipped with x10 objective lens.</p>

<p>20 μM TFP-treated group. The cell were recorded in 2 h after seeding on 6-well plate equipped with x10 objective lens. The video were recorded by Cell Observer (Carl Zeiss, Germany).</p>

<p>Supplementary Figure S1. TFP induces morphological change of U87MG cells, and cell death; Supplementary Figure S2. Body weight is not changed during TFP injection in in vivo glioblastoma skin xenograft model; Supplementary Figure S3. IP3R1, 2 and 3 shRNA knockdown test by western blot and functional knockdown test using GBL 28 primary glioblastoma cells; Supplementary Figure S4. TFP reduces cell viability of several GBL cells;Supplementary Table S1. IP3R 1, 2, 3 and CaM shRNA sequences</p>

<p>Supplementary Figure S1. TFP induces morphological change of U87MG cells, and cell death; Supplementary Figure S2. Body weight is not changed during TFP injection in in vivo glioblastoma skin xenograft model; Supplementary Figure S3. IP3R1, 2 and 3 shRNA knockdown test by western blot and functional knockdown test using GBL 28 primary glioblastoma cells; Supplementary Figure S4. TFP reduces cell viability of several GBL cells;Supplementary Table S1. IP3R 1, 2, 3 and CaM shRNA sequences</p>

<p>20 μM TFP-treated group. The cell were recorded in 2 h after seeding on 6-well plate equipped with x10 objective lens. The video were recorded by Cell Observer (Carl Zeiss, Germany).</p>